CurrentRheuma
Get Weekly

Topic · page 30 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,161–1,200 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus

    Associations between TCA cycle plasma metabolites and fatigue in black females with systemic lupus erythematosus: An untargeted metabolomics pilot study

    Cross-sectional study

  2. Rheumatology (Oxford)

    Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry

    Cohort study

  3. J Rheumatol

    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases

    Cohort study

  4. Rheumatology (Oxford)

    Plasma interferon-alpha protein levels during pregnancy are associated with lower birth weight in systemic lupus erythematosus

    Cohort study

  5. RMD Open

    Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus

    Mechanistic study

  6. Ann Rheum Dis

    Disease activity drives divergent epigenetic and transcriptomic reprogramming of monocyte subpopulations in systemic lupus erythematosus

    Mechanistic study

  7. Ann Rheum Dis

    Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Cross-sectional study

  8. Lancet Rheumatol

    Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

    Cross-sectional study

  9. Lupus

    Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

    Cohort study

  10. Lancet Rheumatol

    Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

    Cohort study

  11. Lupus Sci Med

    Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study

    Cohort study

  12. Lupus

    The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV)

    Cohort study

  13. Lupus Sci Med

    Multidisciplinary re-evaluation of neuropsychiatric events to confirm the neuropsychiatric lupus diagnosis at an Indonesian tertiary hospital

    Cross-sectional study

  14. Lupus

    Impact of intimate partner violence on quality of life and disease activity in women with systemic lupus erythematosus

    Cross-sectional study

  15. Arthritis Res Ther

    A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis

    Randomized controlled trial

  16. Rheumatology (Oxford)

    Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients

    Cohort study

  17. Semin Arthritis Rheum

    Clinical management of lupus in the United States: A claims-based analysis

    Cohort study

  18. JAMA Netw Open

    Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus

    Cohort study

  19. J Rheumatol

    Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations

    Cohort study

  20. J Rheumatol

    Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus

    Research article

  21. Arthritis Care Res (Hoboken)

    Factors Associated With Adherence of Cervical Cancer Screening in Women With Systemic Lupus Erythematosus

    Cross-sectional study

  22. Arthritis Res Ther

    Microstructural changes of the white matter in systemic lupus erythematosus patients without neuropsychiatric symptoms: a multi-shell diffusion imaging study

    Cross-sectional study

  23. Lupus Sci Med

    Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis

    Cohort study

  24. Arthritis Care Res (Hoboken)

    Informing Digital Programs for Lupus Self‐Management Education: A Systematic Scoping Review

    Research article

  25. Arthritis Res Ther

    The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines

    Cohort study

  26. Lupus Sci Med

    Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts

    Cohort study

  27. Lupus

    Association of c.+677 C>T (rs1801133) and c.+1298 A>C (rs1801131) MTHFR genetic variants with cardiometabolic and disease risk in systemic lupus erythematosus patients: A cross-sectional study

    Case-control study

  28. Lupus Sci Med

    iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus

    Diagnostic or prognostic study

  29. Rheumatology (Oxford)

    Disruption of memory B-cell trafficking by belimumab in patients with systemic lupus erythematosus

    Mechanistic study

  30. Rheumatology (Oxford)

    Low-density granulocytes and neutrophil extracellular trap formation are increased in incomplete systemic lupus erythematosus

    Cross-sectional study

  31. Lupus

    Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects

    Meta-analysis

  32. Lupus Sci Med

    Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

    Diagnostic or prognostic study

  33. Semin Arthritis Rheum

    Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

    Diagnostic or prognostic study

  34. J Rheumatol

    Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations

    Research article

  35. Rheumatology (Oxford)

    Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

    Cohort study

  36. Ann Rheum Dis

    EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    Guideline or statement

  37. Lupus Sci Med

    Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history

    Cross-sectional study

  38. Arthritis Res Ther

    Unraveling transcriptomic signatures and dysregulated pathways in systemic lupus erythematosus across disease states

    Mechanistic study

  39. Rheumatology (Oxford)

    Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

    Cohort study

  40. Lupus Sci Med

    Epidemiology of SLE in Italy: an observational study using a primary care database

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,161–1,200 of 1,848, newest first